Scholarlink

Background <p>This study systematically evaluated the potential of porcine platelet-lysate (pPL) as a fetal bovine serum (FBS) substitute in cell culture. By culturing tumor cells, adult cells, and stem cells, it analyzed the differences and advantages of pPL over FBS.</p> Methods <p>pPL was prepared using the freeze - thaw method. Its biological effects were assessed by cell counting, LDH cytotoxicity assays, flow cytometry, and adipogenic/osteogenic/chondrogenic differentiation experiments, combined with qPCR and histological staining.</p> Results <p>pPL significantly promoted the proliferation of A375 and HDF cells, with much lower LDH release than the FBS group, indicating less cellular stress. Flow cytometry showed that MSCs in the pPL group stably expressed mesenchymal markers CD73 ⁺ /CD90 ⁺ (&gt;95%) and had lowCD34 ⁻ (＜2％), meeting ISCT standards. Differentiation experiments revealed that the pPL group had better osteogenic differentiation efficiency, similar chondrogenic ability, and slightly lower but normal adipogenic differentiation compared to the FBS group.</p> Conclusions <p>pPL effectively supports the in vitro expansion of various cells, helps maintain the immunophenotypic stability of MSCs, and shows superiority in osteogenic differentiation. With its unique “proliferation-first, differentiation-controllable” advantage from a natural growth factor network, pPL offers a new approach for developing FBS substitutes.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Systematic evaluation of porcine platelet lysate as a fetal bovine serum substitute: enhancing cell proliferation, maintaining differentiation potential, and ensuring immunophenotypic stability

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年10月28日

查看全文
  • Siqing Chen,
  • Xiaotian Chen,
  • Shijie Meng,
  • Qiang Yuan,
  • Huiling Wu,
  • Weihang Hu,
  • Li Zhou,
  • Letian Shan

摘要

Background

This study systematically evaluated the potential of porcine platelet-lysate (pPL) as a fetal bovine serum (FBS) substitute in cell culture. By culturing tumor cells, adult cells, and stem cells, it analyzed the differences and advantages of pPL over FBS.

Methods

pPL was prepared using the freeze - thaw method. Its biological effects were assessed by cell counting, LDH cytotoxicity assays, flow cytometry, and adipogenic/osteogenic/chondrogenic differentiation experiments, combined with qPCR and histological staining.

Results

pPL significantly promoted the proliferation of A375 and HDF cells, with much lower LDH release than the FBS group, indicating less cellular stress. Flow cytometry showed that MSCs in the pPL group stably expressed mesenchymal markers CD73 ⁺ /CD90 ⁺ (>95%) and had lowCD34 ⁻ (＜2％), meeting ISCT standards. Differentiation experiments revealed that the pPL group had better osteogenic differentiation efficiency, similar chondrogenic ability, and slightly lower but normal adipogenic differentiation compared to the FBS group.

Conclusions

pPL effectively supports the in vitro expansion of various cells, helps maintain the immunophenotypic stability of MSCs, and shows superiority in osteogenic differentiation. With its unique “proliferation-first, differentiation-controllable” advantage from a natural growth factor network, pPL offers a new approach for developing FBS substitutes.